Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

被引:0
|
作者
Gao, Yuchen [1 ]
Chi, Ying [2 ]
Chen, Yunfei [2 ]
Li, Hui Yuan [2 ]
Wang, Wentian [2 ]
Zheng, Wenting [2 ]
Zhu, Ping [2 ]
An, Jinying [3 ,4 ]
Duan, Yanan [3 ,4 ]
Sun, Ting [2 ]
Liu Xiaofan [5 ]
Xue, Feng [5 ]
Liu, Wei [2 ]
Fu, Rongfeng [5 ]
Han, Zhibo [2 ]
Zhang, Yingchi [2 ]
Yang, Renchi [2 ]
Tao, Cheng [2 ]
Wei, Jun [2 ]
Zhang, Xiaomin [3 ,4 ]
Zhang, Lei [5 ]
机构
[1] Inst Hematol & Blo, State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Haihe Lab Cell Ecosyst, State Key Lab Expt Hematol,Natl Clin Res Ctr Bloo, Tianjin, Peoples R China
[3] Tianjin Med Univ, Eye Hosp, Tianjin Key Lab Retinal Funct & Dis, Tianjin Branch,Natl Clin Res Ctr Ocular Dis,Eye I, Tianjin, Peoples R China
[4] Tianjin Med Univ, Sch Optometry, Eye Hosp, Tianjin, Peoples R China
[5] Tianjin Key Lab Gene Therapy Blood Dis, CAMS Key Lab Gene Therapy Blood Dis, Tianjin, Peoples R China
关键词
D O I
10.1182/blood-2022-156764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1974 / 1976
页数:3
相关论文
共 9 条
  • [1] Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study
    Banoei, Mohammad M.
    McIntyre, Lauralyn A.
    Stewart, Duncan J.
    Mei, Shirley H. J.
    Courtman, David
    Watpool, Irene
    Granton, John
    Marshall, John
    dos Santos, Claudia
    Walley, Keith R.
    Schlosser, Kenny
    Fergusson, Dean A.
    Winston, Brent W.
    METABOLITES, 2023, 13 (11)
  • [2] Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
    Chen, Yunfei
    Xu, Yanmei
    Chi, Ying
    Sun, Ting
    Gao, Yuchen
    Dou, Xueqing
    Han, Zhibo
    Xue, Feng
    Li, Huiyuan
    Liu, Wei
    Liu, Xiaofan
    Dong, Huan
    Fu, Rongfeng
    Ju, Mankai
    Dai, Xinyue
    Wang, Wentian
    Ma, Yueshen
    Song, Zhen
    Gu, Jundong
    Gong, Wei
    Yang, Renchi
    Zhang, Lei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [3] Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial
    Parra, Edwin Roger
    Zhang, Jiexin
    Duose, Dzifa Yawa
    Gonzalez-Kozlova, Edgar
    Redman, Mary W.
    Chen, Hong
    Manyam, Ganiraju C.
    Kumar, Gayatri
    Zhang, Jianhua
    Song, Xingzhi
    Lazcano, Rossana
    Marques-Piubelli, Mario L.
    Laberiano-Fernandez, Caddie
    Rojas, Frank
    Zhang, Baili
    Taing, Len
    Jhaveri, Aashna
    Geisberg, Jacob
    Altreuter, Jennifer
    Michor, Franziska
    Provencher, James
    Yu, Joyce
    Cerami, Ethan
    Moravec, Radim
    Kannan, Kasthuri
    Luthra, Rajyalakshmi
    Alatrash, Gheath
    Huang, Hsin-Hui
    Xie, Hui
    Patel, Manishkumar
    Nie, Kai
    Harris, Jocelyn
    Argueta, Kimberly
    Lindsay, James
    Biswas, Roshni
    Van Nostrand, Stephen
    Kim-Schulze, Seunghee
    Gray, Jhanelle E.
    Herbst, Roy S.
    Wistuba, Ignacio I.
    Gettinger, Scott
    Kelly, Karen
    Bazhenova, Lyudmila
    Gnjatic, Sacha
    Lee, J. Jack
    Zhang, Jianjun
    Haymaker, Cara
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1655 - 1668
  • [4] MESENCHYMAL STEM CELL (MSC11FCD) BASED THERAPY ELICITED A FAVORABLE RESPONSE WITH EFFICIENT 5-FU CONVERSION IN PATIENTS WITH RECURRENT GLIOBLASTOMA: AN OPEN LABEL, PHASE I/IIA TRIAL
    Lim, Jaejoon
    Chang, Da-Young
    Sim, Jeongmin
    Jung, Jin-Hwa
    Park, JeongMan
    Kim, Yu Jin
    Kim, Dongkil
    Hwang, Sojung
    Kim, Sung-Soo
    Cho, Hea-Young
    Suh-Kim, Haeyoung
    Cho, Kyunggi
    NEURO-ONCOLOGY, 2023, 25
  • [5] Disorders of Platelet Number or Function: Clinical and Epidemiological Efficacy and Safety of Human Umbilical Cord- Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial
    Chen, Yunfei
    Xu Yanmei
    Gao, Yuchen
    Chi, Ying
    Sun, Ting
    Dou, Xueqing
    Han, Zhibo
    Xue, Feng
    Li, Huiyuan
    Liu, Wei
    Liu, Xiaofan
    Dong, Huan
    Fu, Rongfeng
    Ju, Mankai
    Dai, Xinyue
    Wang, Wentian
    Ma, Yueshen
    Song, Zhen
    Gu, Jundong
    Gong, Wei
    Yang, Renchi
    Zhang, Lei
    BLOOD, 2023, 142
  • [6] Long-term Safety of a Single Infusion of Human Umbilical Cord Blood-derived Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis: The 5-year Follow-up of the Phase I Clinical Trial
    Kim, Min Jung
    Park, Eun Hye
    Shin, Kichul
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3566 - 3567
  • [7] Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial
    Oraee-Yazdani, Saeed
    Tavanaei, Roozbeh
    Rostami, Fatemeh
    Hajarizadeh, Atieh
    Mehrabadi, Marzieh
    Akhlaghpasand, Mohammadhosein
    Tamaddon, Mona
    Khannejad, Samin
    Yazdani, Kaveh Oraii
    Zali, Alireza
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [8] Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial
    Saeed Oraee-Yazdani
    Roozbeh Tavanaei
    Fatemeh Rostami
    Atieh Hajarizadeh
    Marzieh Mehrabadi
    Mohammadhosein Akhlaghpasand
    Mona Tamaddon
    Samin Khannejad
    Kaveh Oraii Yazdani
    Alireza Zali
    Journal of Translational Medicine, 21
  • [9] Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
    Baek, Seung-Hoon
    Shim, Bum-Jin
    Won, Heejae
    Lee, Sunray
    Lee, Yeon Kyung
    Park, Hyun Sook
    Kim, Shin-Yoon
    PHARMACEUTICALS, 2024, 17 (10)